SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-041693
Filing Date
2020-12-09
Accepted
2020-12-09 07:07:33
Documents
14
Period of Report
2020-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131278-8k_intecpharma.htm   iXBRL 8-K 32936
2 PRESS RELEASE ISSUED BY INTEC PHARMA LTD. ON DECEMBER 9, 2020 ea131278ex99-1_intecpharma.htm EX-99.1 6982
3 GRAPHIC ex99-1_001.jpg GRAPHIC 10149
  Complete submission text file 0001213900-20-041693.txt   232630

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ntec-20201209.xsd EX-101.SCH 3194
5 XBRL LABEL FILE ntec-20201209_lab.xml EX-101.LAB 34559
6 XBRL PRESENTATION FILE ntec-20201209_pre.xml EX-101.PRE 22712
7 EXTRACTED XBRL INSTANCE DOCUMENT ea131278-8k_intecpharma_htm.xml XML 3752
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 201376874
SIC: 2834 Pharmaceutical Preparations